Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 3092Triple Negative Breast Neoplasms 504Ovarian Neoplasms 224Colorectal Neoplasms 189Carcinoma, Non-Small-Cell Lung 187Prostatic Neoplasms 180Neoplasms 171Lung Neoplasms 164Neoplasm Metastasis 159Melanoma 116Stomach Neoplasms 113Pancreatic Neoplasms 111Endometrial Neoplasms 105Uterine Cervical Neoplasms 93Squamous Cell Carcinoma of Head and Neck 87Head and Neck Neoplasms 81Colonic Neoplasms 81Carcinoma, Intraductal, Noninfiltrating 80Sarcoma 63Breast Carcinoma In Situ 61Carcinoma, Renal Cell 60Urinary Bladder Neoplasms 59Esophageal Neoplasms 58Motor Activity 57Brain Neoplasms 50Lymphedema 42Breast Cancer Female 40Advanced Breast Cancer 40Liver Neoplasms 39Gastrointestinal Neoplasms 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fasting × Breast × 1 year × Clear all
NCT07387445 2026-05-01

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

University of Illinois at Chicago

Phase NA Recruiting
40 enrolled
Breast

Intermittent Fasting, Breast Neoplasms, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡